000 | 01631 a2200457 4500 | ||
---|---|---|---|
005 | 20250518061924.0 | ||
264 | 0 | _c20200323 | |
008 | 202003s 0 0 eng d | ||
022 | _a1879-0712 | ||
024 | 7 |
_a10.1016/j.ejphar.2019.172667 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYang, Yang | |
245 | 0 | 0 |
_aER-mediated anti-tumor effects of shikonin on breast cancer. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cNov 2019 |
||
300 |
_a172667 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
650 | 0 | 4 |
_aEstrogen Receptor alpha _xmetabolism |
650 | 0 | 4 |
_aEstrogen Receptor beta _xmetabolism |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMCF-7 Cells |
650 | 0 | 4 |
_aNaphthoquinones _xpharmacology |
650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xmetabolism |
650 | 0 | 4 |
_aResting Phase, Cell Cycle _xdrug effects |
700 | 1 | _aGao, Wenya | |
700 | 1 | _aTao, Shiying | |
700 | 1 | _aWang, Yanxia | |
700 | 1 | _aNiu, Jianzhao | |
700 | 1 | _aZhao, Piwen | |
700 | 1 | _aRao, Chenchen | |
700 | 1 | _aYang, Lei | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 863 _gp. 172667 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2019.172667 _zAvailable from publisher's website |
999 |
_c30136409 _d30136409 |